Your browser doesn't support javascript.
loading
Roadmap for ending TB in China by 2035: The challenges and strategies.
Feng, Qishun; Zhang, Guoliang; Chen, Liang; Wu, Huizhong; Yang, Yingzhou; Gao, Qian; Asakawa, Tetsuya; Zhao, Yanlin; Lu, Shuihua; Zhou, Lin; Lu, Hongzhou.
Afiliación
  • Feng Q; National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, Guangdong, China.
  • Zhang G; National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, Guangdong, China.
  • Chen L; Guangdong Provincial Research Center for Public Health, Guangdong Provincial Center for Diseases Control and Prevention, Guangzhou, Guangdong, China.
  • Wu H; Guangdong Provincial Center for Tuberculosis Control, Guangzhou, Guangdong, China.
  • Yang Y; Shenzhen Center for Chronic Disease Control, Shenzhen, Guangdong, China.
  • Gao Q; National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, Guangdong, China.
  • Asakawa T; School of Basic Medical Science, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zhao Y; National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, Guangdong, China.
  • Lu S; National Tuberculosis Reference Laboratory, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Zhou L; National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, Guangdong, China.
  • Lu H; National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Biosci Trends ; 18(1): 11-20, 2024 Mar 19.
Article en En | MEDLINE | ID: mdl-38325824
ABSTRACT
Tuberculosis (TB) is one of the top ten causes of death worldwide, taking the lives of over a million people annually. In addition to being a serious health issue, TB is also closely linked to eradicating poverty according to the Sustainable Development Goals (SDGs) of the United Nations (UN). All UN members have committed to ending the TB epidemic by 2030. China has one of the highest TB loads worldwide, ranking third in the world on many TB burden indices. The national strategy for TB control is aimed at creating a collaborative network and integrating TB treatment into the medical system. According to the WHO's global TB report, China is expected to have 748,000 new cases of TB in 2022 and an incidence of 52 cases per 100,000 people. Ending TB remains a huge challenge and requires comprehensive control strategies in China. In this work, we have discussed the challenges of TB prevention and control in China and proposed specific measures to end TB.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Biosci Trends Asunto de la revista: BIOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Biosci Trends Asunto de la revista: BIOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Japón